Daxor (NASDAQ:DXR) filed a Form 4 reporting the grant of 2,500 non-qualified stock options to director Joy S. Goudie on June 24 2025 at an exercise price of $9.29 per share, expiring June 24 2030.
The award is contingent upon SEC approval of an amendment to the company’s 2020 Incentive Compensation Plan and vests in three tranches: 833 options on June 24 2025, 883 on June 24 2026, and 834 on June 24 2027. No open-market purchases or sales were disclosed; the filing solely records the new derivative position. Following the transaction, Goudie beneficially owns 2,500 options with no change to her reported direct share ownership.
Daxor Corporation (DXR) filed a Form 4 on 26-Jun-2025 disclosing that director Caleb DesRosiers received 2,500 non-qualified stock options on 24-Jun-2025. The options carry an exercise price of $9.29 and expire on 24-Jun-2030. Vesting occurs in three installments: 833 options on 24-Jun-2025, 833 on 24-Jun-2026 and 834 on 24-Jun-2027. Following the grant, DesRosiers beneficially owns 2,500 derivative securities directly.
The award is contingent on SEC approval of an amendment to the Daxor Corporation 2020 Incentive Compensation Plan. No common-stock purchases or sales were reported, making this a routine compensation-related disclosure rather than a signal of insider sentiment.